Wednesday, August 29, 2012 9:25:23 AM
Today : Wednesday 29 August 2012
Medivation, Inc. (NASDAQ: MDVN) today announced a 2-for-1 forward split of its common stock with a Record Date of September 7, 2012. The forward split will take effect on the Payable Date, September 21, 2012, and Medivation's common stock will begin trading on a post-split basis on the NASDAQ Global Market on September 24, 2012.
On the Payable Date, every one (1) share of the Company's pre-split common stock held by a shareholder as of the Record Date, including shares subject to outstanding stock options and shares available for grant under the Company's equity incentive plans, will automatically be split into two (2) shares of the Company's post-split common stock. The forward split will affect all stockholders uniformly and will not affect any stockholder's ownership percentage. Additional information regarding the forward split can be found in Medivation's definitive proxy statement filed with the Securities and Exchange Commission on June 1, 2012.
About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM